Pfizer To Sue Drug Maker Seeking FDA OK To Market Generic Detrol

Law360, New York (March 10, 2004, 12:00 AM EST) -- Pfizer Inc. intends to file a patent infringement lawsuit "shortly" against an unspecified company that is seeking to market a generic version of its Detrol incontinence drug, the drug maker said in a regulatory filing this week.

In its annual report filed with the Securities and Exchange Commission, Pfizer said another manufacturer told Pfizer in February that it had filed an abbreviated new drug application with U.S. Food and Drug Administration seeking approval to market a generic form of Detrol, used to treat overactive bladder conditions....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.